SEC Form 4 · accession 0001493152-18-016878
enVVeno Medical Corp · NVNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benedict Broennimann
Officer — Chief Medical Officer, OUS
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001661053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Common StockF2,F3 | Nov 27, 2018 | A | 3,334 | — | A | 437,778 | I | By Rosewall Ventures Ltd. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The issuer entered into a services agreement with Rosewall Ventures Ltd. ("Rosewall"), dated May 1, 2018 (the "Service Agreement"), whereby Rosewall is providing the services of Ben Broennimann as the Company's Chief Medical Officer - Out of U.S.. The Service Agreement provides for the monthly payment of fifteen thousand dollars ($15,000) (the " Rosewall Monthly Fee"), provided however that the Company may, at its sole option, elect to pay twenty five percent (25%) of the Rosewall Monthly Fee in company common stock, par value $0.0001 per share (the "Common Stock"), with the number of Common Stock determined by dividing three thousand seven hundred fifty dollars ($3,750) by the closing price of Common Stock on the second (2nd) work day of each month. On November 27, 2018, the Company elected to issue Rosewall Common Stock for the months of October and November.
- F2The closing price of the Common Stock on the 2nd work day of October was $2.57 and it was $2.00 for the 2nd work day of November.
- F3Dr. Benedict Broennimann is the chairman of Rosewall Ventures Ltd.